Cited by 326Nuclear Receptors and SignalingParkinson's Disease Mechanisms and TreatmentsNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 87 of the 89 references it cites were found in a registry or an index.

The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease

Jankovic, J., Chen, S., Le, W.D.·2005·Progress in Neurobiology

DOI 10.1016/j.pneurobio.2005.09.001

Open this paper in CoChat — free account

Abstract

Nurr1, a transcription factor belonging to the orphan nuclear receptor superfamily, is critical in the development and maintenance of the dopaminergic system and as such it may have role in the pathogenesis of Parkinson' disease (PD). Human Nurr1 gene has been mapped to chromosome 2q22-23 and Nurr1 protein is predominantly expressed in central dopaminergic neurons. Nurr1 interacts with other factors critical for the survival of mensencephalic dopaminergic neurons and it appears to regulate the expression of tyrosine hydroxylase (TH), dopamine transporter (DAT), vesicular monoamine transporter 2 (VMAT2), and l-aromatic amino acid decarboxylase (AADC), all of which are important in the synthesis and storage of dopamine. Experimental studies in Nurr1 knock-out mice indicate that Nurr1 deficiency results in impaired dopaminergic function and increased vulnerability of those midbrain dopaminergic neurons that degenerate in PD. Decreased Nurr1 expression is found in the autopsied PD midbrains, particularly in neurons containing Lewy bodies, as well as in peripheral lymphocytes of patients with parkinsonian disorders. Several variants in Nurr1 gene have been reported in association with PD. All these studies suggest that Nurr1 is not only essential in the development of mensencephalic dopaminergic neurons and maintenance of their functions, but it may also play a role in the pathogenesis of PD.

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2005.09.001

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Nolte, R. T., Wisely, G. B., Westin, S. K., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,979
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,674
Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease
Kim, J., Auerbach, J. M., Rodríguez‐Gómez, J. A., Velasco, I., Gavin, D. K., Lumelsky, N. L., Lee, S., Nguyen, J., Sánchez‐Pernaute, R., Bankiewicz, K. S., et al. (2002) · Nature · doi:10.1038/nature00900 · Cited by 1,598
Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
Renaud, J., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., & Moras, D. (1995) · Nature · doi:10.1038/378681a0 · Cited by 1,118
Dopamine Neuron Agenesis in Nurr1-Deficient Mice
Zetterström, R. H., Solomin, L., Jansson, L., Hoffer, B. J., Olson, L., & Perlmann, T. (1997) · Science · doi:10.1126/science.276.5310.248 · Cited by 1,096
Derivation of midbrain dopamine neurons from human embryonic stem cells
Perrier, A. L., Tabar, V. S., Barberi, T., Rubio, M. E., Brusés, J. L., Topf, N., Harrison, N. L., & Studer, L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404700101 · Cited by 1,007
Parkinson’s Disease and Movement Disorders
Tn, M., & Bhattacharyya, K. (2005) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10587 · Cited by 802
Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons
Cárdenas, O. S., Quintana-Hau, J. D. D., Le, W., Smidt, M. P., Cox, J. J., Mayo, F. J. D., Burbach, J. P. H., & Conneely, O. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.4013 · Cited by 745
Self-citation

Show all 89 references

Research works printed but not linked: 5

Grimes, 2004, A novel mutation in the Nurr1 gene in Parkinson's disease, Mov. Disord., 19, 1120
Jiang, 2004, Effects of ropinirole on progression of parkinsonism in Nurr1 deficient mice and its underlying mechanism, Neurology, 62, A7
Le, 2004, Nurr1 gene targeting therapy for Parkinson's disease, Mov. Dis., 19, S132
Pan, 2005, Reduction of Nurr1 mRNA in human peripheral blood lymphocytes in Parkinson disease, Ann. Neurol.
Pan, 2005, Radicicol induces heat shock protein expression and neuroprotection against rotenone-mediated apoptosis in SH-SY5Y cells, Mov. Dis., S86

Sorted by citations

Items 101–200 of 326

CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK/AKT-Nurr1 signal pathways
Han, Q.-W., Shao, Q.-H., Wang, X., Ma, K., Chen, N., & Yuan, Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00853-8 · Cited by 40
Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice
Rojas, P., Ruiz-Sánchez, E., Rojas, C., & Ögren, S. O. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.004 · Cited by 41
Neural differentiation and potential use of stem cells from the human umbilical cord for central nervous system transplantation therapy
Low, C. B., Liou, Y., & Tang, B. L. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21624 · Cited by 41
Transplantation of post‐mitotic human neuroteratocarcinoma‐overexpressing Nurr1 cells provides therapeutic benefits in experimental stroke: In vitro evidence of expedited neuronal differentiation and GDNF secretion
Hara, K., Matsukawa, N., Yasuhara, T., Xu, L., Yu, G., Maki, M., Kawase, T., Hess, D. C., Kim, S. U., & Borlongan, C. V. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21234 · Cited by 41
The Nurr1 Ligand,1,1-bis(3′-Indolyl)-1-(p-Chlorophenyl)Methane, Modulates Glial Reactivity and Is Neuroprotective in MPTP-Induced Parkinsonism
Hammond, S. L., Popichak, K. A., Li, X., Hunt, L. G., Richman, E. H., Damale, P. U., Chong, E. K. P., Backos, D. S., Safe, S. H., & Tjalkens, R. B. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.246389 · Cited by 43
NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder
Lévy, J., Grotto, S., Mignot, C., Maruani, A., Delahaye‐Duriez, A., Benzacken, B., Keren, B., Haye, D., Xavier, J., Heulin, M., et al. (2018) · Clinical Genetics · doi:10.1111/cge.13383 · Cited by 40
Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic‐based therapies
Renani, P. G., Taheri, F., Rostami, D., Farahani, N., Abdolkarimi, H., Abdollahi, E., Taghizadeh, E., & Hayat, S. M. G. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28622 · Cited by 43
Exogenous Nurr1 gene expression in electrically-stimulated human MSCs and the induction of neurogenesis
Park, J. S., Yang, H. N., Woo, D. G., Jeon, S. Y., Do, H., Huh, S.-H., Kim, H. N., Kim, J.-H., & Park, K.-H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.069 · Cited by 39
Maternal Separation Impairs Cocaine-Induced Behavioural Sensitization in Adolescent Mice
Gracia‐Rubio, I., Laorden, E. M., Moscoso‐Castro, M., Milanés, M. V., Laorden, M. L., & Valverde, O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167483 · Cited by 42
Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
Li, T., Yang, Z., Li, S., Cheng, C., Shen, B., & Le, W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00392 · Cited by 39
Self-citation
NURR1 deficiency is associated to ADHD-like phenotypes in mice
Montarolo, F., Martire, S., Perga, S., Spadaro, M., Brescia, I. V., Allegra, S., Francia, S. D., & Bertolotto, A. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0544-0 · Cited by 39
Association analysis of 15 polymorphisms within 10 candidate genes for antisocial behavioural traits
Prichard, Z. M., Jorm, A. F., Mackinnon, A. J., & Easteal, S. (2007) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32816ebc9e · Cited by 39
Nurr1 Expression and Its Modulation in Microglia
Fan, X., Luo, G., Ming, M., Pu, P., Li, L., Yang, D., & Le, W. (2009) · NeuroImmunoModulation · doi:10.1159/000204229 · Cited by 39
Self-citation
9-Methyl-β-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture
Hamann, J., Wernicke, C., Lehmann, J., Reichmann, H., Rommelspacher, H., & Gille, G. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.08.018 · Cited by 39
The Role of Otx2 in Adult Mesencephalic–Diencephalic Dopaminergic Neurons
Simeone, A., Salvio, M. D., Giovannantonio, L. G. D., Acampora, D., Omodei, D., & Tomasetti, C. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8148-y · Cited by 38
Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson’s Disease in Rats
Kandil, E. A., Sayed, R. H., Ahmed, L. A., Fattah, M. A. A. E., & El‐Sayeh, B. M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0636-x · Cited by 38
Recent Progress in Non-motor Features of Parkinson’s Disease with a Focus on Circadian Rhythm Dysregulation
Liu, Y., Niu, L., Liu, X., Cheng, C., & Le, W. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00711-x · Cited by 39
Self-citation
Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson’s Disease Rat Model
Sun, C., Wang, Y., Mo, M., Song, C., Wang, X., Chen, S., & Liu, Y. (2019) · BioMed Research International · doi:10.1155/2019/6843265 · Cited by 37
Self-citation
α-Synuclein Negatively Regulates Nurr1 Expression Through NF-κB-Related Mechanism
Jia, C., Qi, H., Cheng, C., Wu, X., Yang, Z., Cai, H., Chen, S., & Le, W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00064 · Cited by 37
Self-citation
Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression
Chawla, A., Cakmakci, D., Fiori, L. M., Zang, W., Maitra, M., Yang, J., Żurawek, D., Frosi, G., Rahimian, R., Mitsuhashi, H., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02249-4 · Cited by 39
A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1 mice
Zhang, J., Götz, S., Weisenhorn, D. M. V., Simeone, A., Wurst, W., & Prakash, N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.05.015 · Cited by 36
NR4A Gene Expression Is Dynamically Regulated in the Ventral Tegmental Area Dopamine Neurons and Is Related to Expression of Dopamine Neurotransmission Genes
Eells, J. B., Wilcots, J., Sisk, S., & Guo‐Ross, S. X. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9642-z · Cited by 36
Hemiparkinsonism-hemiatrophy syndrome
Wijemanne, S., & Jankovic, J. J. (2007) · Neurology · doi:10.1212/01.wnl.0000277699.48155.39 · Cited by 36
Self-citation
Recent developments in gene therapy for Parkinson’s disease
Szunyogh, S., Carroll, E., & Wade‐Martins, R. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.030 · Cited by 39
Thyroid Dysfunction and Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis
Charoenngam, N., Rittiphairoj, T., Ponvilawan, B., & Prasongdee, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.863281 · Cited by 36
Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo
Pan, T., Zhu, W., Zhao, H., Deng, H., Xie, W., Jankovic, J. J., & Le, W. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.022 · Cited by 35
Self-citation
Mechanisms of microRNA-132 in central neurodegenerative diseases: A comprehensive review
Mu, C., Gao, M., Xu, W., Sun, X., Chen, T., Xu, H., & Qiu, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116029 · Cited by 37
The role of nuclear receptors in controlling the fine balance between proliferation and differentiation of neural stem cells
Στεργιόπουλος, Α., & Politis, P. K. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.09.009 · Cited by 38
Expression of functional dopaminergic phenotype in purified cultured Müller cells from vertebrate retina
Kubrusly, R. C. C., Panizzutti, R., Gardino, P. F., Stutz, B., Reis, R. A. D. M., Ventura, A. L. M., de Mello, M. C. F., & Mello, F. G. D. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.05.002 · Cited by 34
α7 Nicotinic receptor agonist reactivates neurogenesis in adult brain
Narla, S. T., Klejbor, I., Birkaya, B. G., Lee, Y.-W., Moryś, J., Stachowiak, E. K., Terranova, C. J., Bencherif, M., & Stachowiak, M. K. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.028 · Cited by 34
Rapid increase of Nurr1 mRNA expression in limbic and cortical brain structures related to coping with depression‐like behavior in mice
Rojas, P., Joodmardi, E., Perlmann, T., & Ögren, S. O. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22377 · Cited by 34
Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1
Green, A. L., Zhan, L., Eid, A., Zarbl, H., Guo, G. L., & Richardson, J. R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.07.020 · Cited by 33
An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation
Serva, S. N., Bernstein, J., Thompson, J. A., Kern, D. S., & Ojemann, S. G. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.863921 · Cited by 37
Contexts for Dopamine Specification by Calcium Spike Activity in the CNS
Velazquez-Ulloa, N. A., Spitzer, N. C., & Dulcis, D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3542-10.2011 · Cited by 33
Protective effects of a herbal extract combination of Bupleurum falcatum , Paeonia suffruticosa , and Angelica dahurica against MPTP-induced neurotoxicity via regulation of nuclear receptor-related 1 protein
Sim, Y., Park, G., Eo, H., Huh, E., Gu, P. S., Hong, S.-P., Pak, Y. K., & Oh, M. S. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.10.029 · Cited by 33
Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington’s disease
Jahanshahi, A., Vlamings, R., van Roon‐Mom, W., Faull, R. L. M., Waldvogel, H. J., Janssen, M. L. F., Yakkioui, Y., Zeef, D. H., Kocabıçak, E., Steinbusch, H. W. M., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.071 · Cited by 32
Nuclear receptors in neural stem/progenitor cell homeostasis
Gkikas, D., Tsampoula, M., & Politis, P. K. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2571-4 · Cited by 33
Lymphocyte Proteomics of Parkinson‘s Disease Patients Reveals Cytoskeletal Protein Dysregulation and Oxidative Stress
Mila, S., Albo, A. G., Corpillo, D., Giraudo, S., Zibetti, M., Bucci, E. M., Lopiano, L., & Fasano, M. (2009) · Biomarkers in Medicine · doi:10.2217/bmm.09.4 · Cited by 32
Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson’s Disease
Al‐Nusaif, M., Lin, Y., Li, T., Cheng, C., & Le, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416184 · Cited by 32
Self-citation
Induction of Neurotrophic and Differentiation Factors in Neural Stem Cells by Valproic Acid
Almutawa, W., Kang, N. H., Pan, Y., & Niles, L. P. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12201 · Cited by 32
LRRK2: an éminence grise of Wnt-mediated neurogenesis?
Berwick, D. C., & Harvey, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00082 · Cited by 33
Regulation of GTP cyclohydrolase I expression by orphan receptor Nurr1 in cell culture andin vivo
Gil, M., McKinney, C., Lee, M. K., Eells, J. B., Phyillaier, M., & Nikodem, V. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04356.x · Cited by 31
Ultrasound‐triggered effects of the microbubbles coupled to GDNF‐ and Nurr1‐loaded PEGylated liposomes in a rat model of Parkinson's disease
Yue, P., Gao, L., Wang, X., Ding, X., & Teng, J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26608 · Cited by 31
Transcriptomic Characterization of the Human Insular Cortex and Claustrum
Ibrahim, C., Foll, B. L., & French, L. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00094 · Cited by 31
Neurogenic differentiation of human conjunctiva mesenchymal stem cells on a nanofibrous scaffold
Soleimani, M., Nadri, S., & Shabani, I. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.092999ms · Cited by 30
A hidden layer of structural variation in transposable elements reveals potential genetic modifiers in human disease-risk lociPreprint
van Bree, E. J., Guimarães, R. L. F. P., Lundberg, M., Blujdea, E. R., Rosenkrantz, J. L., White, F. T. G., Poppinga, J., Ferrer‐Raventós, P., Schneider, A.-F. E., Clayton, I., et al. (2022) · Genome Research · doi:10.1101/gr.275515.121 · Cited by 30
A New Experimental Model for Neuronal and Glial Differentiation Using Stem Cells Derived from Human Exfoliated Deciduous Teeth
Jarmalavičiūtė, A., Tunaitis, V., Strainienė, E., Aldonytė, R., Ramanavičius, A., Venalis, A., Magnusson, K., & Pivoriūnas, A. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0046-0 · Cited by 29
Roles of Transcription Factors in the Development and Reprogramming of the Dopaminergic Neurons
Tian, L., Al‐Nusaif, M., Chen, X., Li, S., & Le, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020845 · Cited by 29
Self-citation
PPARs and Their Neuroprotective Effects in Parkinson’s Disease: A Novel Therapeutic Approach in α-Synucleinopathy?
Pérez-Segura, I., Santiago-Balmaseda, A., Rodríguez-Hernández, L. D., Morales-Martínez, A., Martínez-Becerril, H. A., Martínez-Gómez, P. A., Delgado-Minjares, K. M., Salinas‐Lara, C., Martínez-Dávila, I. A., Guerra‐Crespo, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043264 · Cited by 29
The BCL2 code to dopaminergic development and Parkinson's disease
van der Heide, L. P., & Smidt, M. P. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.02.003 · Cited by 29
Generation of Dopamine Neurons with Improved Cell Survival and Phenotype Maintenance Using a Degradation-Resistant Nurr1 Mutant
Jo, A.-Y., Kim, M.-Y., Lee, H., Rhee, Y., Lee, J. E., Baek, K., Park, C., Koh, H.-C., Shin, I., Lee, Y., et al. (2009) · Stem Cells · doi:10.1002/stem.146 · Cited by 29
Reduced tyrosine hydroxylase and GTP cyclohydrolase mRNA expression, tyrosine hydroxylase activity, and associated neurochemical alterations in Nurr1-null heterozygous mice
Eells, J. B., Misler, J. A., & Nikodem, V. M. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.05.004 · Cited by 29
Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization
Scheepstra, M., Andrei, S. A., de Vries, R. M. J. M., Meijer, F. A., Ma, J., Burstein, E. S., Olsson, R., Ottmann, C., Milroy, L. ‐., & Brunsveld, L. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00216 · Cited by 30
Iron Ion-Releasing Polypeptide Thermogel for Neuronal Differentiation of Mesenchymal Stem Cells
Patel, M., Lee, H. J., Son, S., Kim, H., Kim, J., & Jeong, B. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b01096 · Cited by 28
Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases
Zhang, L., Liu, Y., Lu, Y., & Wang, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115295 · Cited by 29
Immunocytochemical expression of dopamine‐related transcription factors Pitx3 and Nurr1 in prenatally stressed adult rats
Katunar, M. R., Saez, T. M. M., Brusco, A., & Antonelli, M. C. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21911 · Cited by 28
Hypoxia‐inducible factor 1 alpha and nuclear‐related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease
Kandil, E. A., Sayed, R. H., Ahmed, L. A., Fattah, M. A. A. E., & El‐Sayeh, B. M. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13162 · Cited by 30
Chronic waterborne exposure to benzo[a]pyrene induces locomotor dysfunction and development of neurodegenerative phenotypes in zebrafish
Das, S. K., Aparna, S., & Patri, M. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134646 · Cited by 29
Pharmacological Stimulation of Nurr1 Promotes Cell Cycle Progression in Adult Hippocampal Neural Stem Cells
Moon, H., Jeon, S. G., Kim, J.-I., Kim, H. S., Lee, S. H., Kim, D., Park, S., Moon, M., & Chung, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010004 · Cited by 29
Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson’s Disease. A Systematic Review
Kambey, P. A., Kanwore, K., Ayanlaja, A. A., Nadeem, I., Yinzhen, D., Buberwa, W., Liu, W., & Gao, D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.645583 · Cited by 27
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
Klemann, C. J. H. M., Martens, G. J. M., Poelmans, G., & Visser, J. E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9103-8 · Cited by 29
Analogs of the Dopamine Metabolite 5,6-Dihydroxyindole Bind Directly to and Activate the Nuclear Receptor Nurr1
Kholodar, S. A., Lang, G., Cortopassi, W. A., Iizuka, Y., Brah, H., Jacobson, M. P., & England, P. M. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00326 · Cited by 26
Activation of Developmental Nuclear Fibroblast Growth Factor Receptor 1 Signaling and Neurogenesis in Adult Brain by α7 Nicotinic Receptor Agonist
Narla, S. T., Klejbor, I., Birkaya, B. G., Lee, Y., Moryś, J., Stachowiak, E. K., Prokop, D., Bencherif, M., & Stachowiak, M. K. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0103 · Cited by 26
α-Synuclein Induces the GSK-3-Mediated Phosphorylation and Degradation of NURR1 and Loss of Dopaminergic Hallmarks
García‐Yagüe, Á. J., Lastres‐Becker, I., Stefanis, L., Vassilatis, D. K., & Cuadrado, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02558-9 · Cited by 26
Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson’s Disease
Usenko, T. S., Bezrukova, A. I., Basharova, K. S., Panteleeva, A., Nikolaev, M. A., Kopytova, A. E., Miliukhina, I. V., Emelyanov, A., Zakharova, E. Y., & Pchelina, S. (2021) · Genes · doi:10.3390/genes12101545 · Cited by 25
Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson’s disease
Lu, J., Xu, Y. C., Quan, Z., Chen, Z., Sun, Z., & Qing, H. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.09.033 · Cited by 24
Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease
Pascale, E., Divisato, G., Palladino, R., Auriemma, M., Ngalya, E. F., & Caiazzo, M. (2020) · Biomolecules · doi:10.3390/biom10091269 · Cited by 24
Genetic intersection between dystonia and neurodevelopmental disorders: Insights from genomic sequencing
Dzinovic, I., Winkelmann, J., & Zech, M. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.08.019 · Cited by 24
Nurr1 and PPARγ protect PC12 cells against MPP+ toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairment
Farshbaf, M. J., Forouzanfar, M., Ghaedi, K., Kiani-Esfahani, A., Peymani, M., Shoaraye-nejati, A., Izadi, T., Karbalaie, K., Noorbakhshnia, M., Rahgozar, S., et al. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2764-4 · Cited by 26
Cicadidae Periostracum, the Cast-Off Skin of Cicada, Protects Dopaminergic Neurons in a Model of Parkinson’s Disease
Lim, H., Kim, J., Moon, B. C., Choi, G., Ryu, S. M., Lee, J. H., Ang, M. J., Jeon, M., Moon, C., & Park, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5797512 · Cited by 24
BMP2 promotes the differentiation of neural stem cells into dopaminergic neurons in vitro via miR-145-mediated upregulation of Nurr1 expression.
Wang, Y., Chen, Z., Chen, J., & Chen, H. (2016) · PubMed Central · Cited by 24
Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal
García‐Pérez, D., Núñez, C., Laorden, M. L., & Milanés, M. V. (2014) · Addiction Biology · doi:10.1111/adb.12209 · Cited by 23
Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawal
García‐Pérez, D., López-Bellido, R., Rodrı́guez, R. E., Laorden, M. L., Núñez, C., & Milanés, M. V. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0761-5 · Cited by 24
Terminal Differentiation of Mesodiencephalic Dopaminergic Neurons:
Smidt, M. P., Burbach, J. P. H., & Burbach, H. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0322-8_4 · Cited by 23
Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in in Vitro Models of Parkinson’s Disease via Up-regulation of the Wnt/β-Catenin Pathway
Baldeschi, A. C., Pittaluga, E., Andreola, F., Rossi, S., Cozzolino, M., Nicotera, G., Sferrazza, G., Pierimarchi, P., & Serafino, A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00020 · Cited by 22
Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson’s Disease
Contaldi, E., Magistrelli, L., Milner, A. V., Cosentino, M., Marino, F., & Comi, C. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202417 · Cited by 22
Nurr1 Cd11bcre conditional knockout mice display inflammatory injury to nigrostriatal dopaminergic neurons
Dong, J., Liu, X., Wang, Y. Y., Cai, H., & Le, W. (2020) · Glia · doi:10.1002/glia.23826 · Cited by 22
Self-citation
Animal Models of Parkinson’s Disease
Blesa, J., Trigo‐Damas, I., Quiroga‐Varela, A., & del Rey, N. L. (2016) · InTech eBooks · doi:10.5772/63328 · Cited by 24
Peripheral Biomarkers of Parkinson‘s Disease as Early Reporters of Central Neurodegeneration
Fasano, M., Alberio, T., & Lopiano, L. (2008) · Biomarkers in Medicine · doi:10.2217/17520363.2.5.465 · Cited by 24
Tetrahedral DNA nanostructures functionalized by multivalent microRNA132 antisense oligonucleotides promote the differentiation of mouse embryonic stem cells into dopaminergic neurons
Wei, M., Li, S., Yang, Z., Cheng, C., Li, T., & Le, W. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102375 · Cited by 21
Self-citation
A review of psychostimulant-induced neuroadaptation in developing animals
CARREY, N. J., & Wilkinson, M. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1004-x · Cited by 21
Morphine administration modulates expression of A rgonaute 2 and dopamine‐related transcription factors involved in midbrain dopaminergic neurons function
García‐Pérez, D., Sáez, F., Laorden, M. L., Núñez, C., & Milanés, M. V. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12083 · Cited by 21
Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor–Nuclear Receptor Related 1 Protein Dimer Activation
Sundén, H., Schäfer, A., Scheepstra, M., Leysen, S., Malo, M., Ma, J., Burstein, E. S., Ottmann, C., Brunsveld, L., & Olsson, R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01702 · Cited by 21
Transplantation of Nurr1‐overexpressing neural stem cells and microglia for treating parkinsonian rats
Yuan, Q., Chen, X., Wang, W., Li, J., Wang, X., Tang, Z., Xu, J., Lin, H. Y., Yang, Z., Li, L., et al. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13149 · Cited by 21
Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed?
Kansara, S., Trivedi, A., Chen, S., Jankovic, J. J., & Le, W. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0840-9 · Cited by 21
Self-citation
Chronic cocaine administration modulates the expression of transcription factors involved in midbrain dopaminergic neuron function
Leo, D., di Porzio, U., Racagni, G., Riva, M. A., Fumagalli, F., & Perrone‐Capano, C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.024 · Cited by 21
Dr. Jekyll or Mr. Hyde: The multifaceted roles of miR-145-5p in human health and disease
Rahman, M. S., Ghorai, S., Panda, K., Santiago, M. J., Aggarwal, S., Wang, T., Rahman, I., Chinnapaiyan, S., & Unwalla, H. J. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.11.001 · Cited by 21
A High-Efficiency Induction of Dopaminergic Cells from Human Umbilical Mesenchymal Stem Cells for the Treatment of Hemiparkinsonian Rats
Ko, T.-L., Fu, Y.-Y., Lin, Y., Lin, Y., Ko, M., Fu, T.-W., Lin, T.-Y., Hsiao, H.-S., Chu, P., & Fu, Y.-S. (2015) · Cell Transplantation · doi:10.3727/096368914x685078 · Cited by 20
The orphan nuclear receptor DHR38 influences transcription of the DOPA decarboxylase gene in epidermal and neural tissues ofDrosophila melanogaster
Davis, M. M., Yang, P., Chen, L., O’Keefe, S. L., & Hodgetts, R. B. (2007) · Genome · doi:10.1139/g07-084 · Cited by 20
The role of developmental transcription factors in adult midbrain dopaminergic neurons
Doucet-Beaupré, H., & L�vesque, M. (2013) · OA Neurosciences · doi:10.13172/2054-7358-1-1-947 · Cited by 19
Long 3'UTR of Nurr1 mRNAs is targeted by miRNAs in mesencephalic dopamine neurons
Pereira, L. A. S., Munita, R., González, M., & Andrés, M. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188177 · Cited by 18
Mechanisms of NURR1 Regulation: Consequences for Its Biological Activity and Involvement in Pathology
García‐Yagüe, Á. J., & Cuadrado, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512280 · Cited by 18
Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice
Vuillermot, S., Feldon, J., & Meyer, U. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.07.008 · Cited by 18
Murine dopaminergic Müller cells restore motor function in a model of Parkinson's disease
Stutz, B., da Conceição, F. S. L., Santos, L. E., Cadilhe, D. V., Fleming, R. L., Acquarone, M., Gardino, P. F., Reis, R. A. D. M., Dickson, P. W., Dunkley, P. R., et al. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12475 · Cited by 18
Upregulation of mir-132 induces dopaminergic neuronal death via activating SIRT1/P53 pathway
Qazi, T. J., Lu, J., Duru, L. N., Zhao, J., & Qing, H. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135465 · Cited by 20
Transcription Factors: Potential Cell Death Markers in Parkinson’s Disease
Wang, R., Yang, S., Nie, T., Zhu, G., Feng, D., & Yang, Q. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0168-4 · Cited by 17
Increased dopaminergic innervation in the brain of conditional mutant mice overexpressing Otx2: Effects on locomotor behavior and seizure susceptibility
Tripathi, P. P., Giovannantonio, L. G. D., SANGUINETTI, E. L., Acampora, D., Allegra, M., Caleo, M., Wurst, W., Simeone, A., & Bozzi, Y. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.12.045 · Cited by 17
Activation of Nurr1 with Amodiaquine Protected Neuron and Alleviated Neuroinflammation after Subarachnoid Hemorrhage in Rats
Chen, H., Yu, X., Hu, L., Peng, Y., Yu, Q., Zhou, H., Xu, C., Zeng, H., Cao, Y., Zhuang, J., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6669787 · Cited by 16
Pediatric-Onset Epilepsy and Developmental Epileptic Encephalopathies Followed by Early-Onset Parkinsonism
Spagnoli, C., Fusco, C., & Pisani, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043796 · Cited by 16
NR4A2 as a Novel Target Gene for Developmental and Epileptic Encephalopathy: A Systematic Review of Related Disorders and Therapeutic Strategies
Gabaldón-Albero, A., Mayo, S., & Martı́nez, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105198 · Cited by 16

Authors: Jankovic, J., Chen, S., & Le, W. D.
Affiliations: Baylor College of Medicine (US)
Shanghai Jiao Tong University (CN)
Corresponding author: Le, W.D.
ORCID: Jankovic, J.
Chen, S.
Le, W.D.
Venue: Progress in Neurobiology
Publisher: Elsevier BV
Published: 2005-09
Volume: 77
Issue: 1-2
Pages: 128-138
ISSN: 0301-0082 (ISSN-L)
DOI: 10.1016/j.pneurobio.2005.09.001
OpenAlex: W2048841722
Cited by: 325
References: 89
Citations by year: 2026: 10 · 2025: 8 · 2024: 15 · 2023: 14 · 2022: 21 · 2021: 22 · 2020: 13 · 2019: 19 · 2018: 13 · 2017: 19 · 2016: 15 · 2015: 18 · 2014: 16 · 2013: 22 · 2012: 16
FWCI: 1.06
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Progress in Neurobiology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Neurological Disorders and Stroke (NS043567, R01NS043567, NS40370, R01NS040370)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: Nurr1, Parkinson's disease, dopaminergic neurons, midbrain, transcription factors, orphan nuclear receptor, tyrosine hydroxylase, dopamine transporter, vesicular monoamine transporter 2, aromatic L-amino acid decarboxylase, Lewy bodies, dopaminergic neuron development, dopaminergic neuron survival
MeSH terms: Animals, Brain, Cell Differentiation, DNA-Binding Proteins, Dopamine, Humans, Neurons, Parkinson Disease, Transcription Factors, Signal Transduction, Nuclear Receptor Subfamily 4, Group A, Member 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks